A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Effectiveness and Safety of ALGRX 3268 [lidocaine] in Pediatric Subjects
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2015
At a glance
- Drugs Lidocaine (Primary)
- Indications Procedural pain
- Focus Therapeutic Use
- Sponsors AlgoRx Pharmaceuticals
- 01 Sep 2015 Results published in Marathon Pharmaceuticals media release.
- 02 Oct 2007 New trial record.